Halo Labs Inc (NEO:HALO) Increasing Evidence of Higher Cannabis Demand
Halo Labs Inc (NEO:HALO) (OTCMKTS:AGEEF) (FRA:A9KN) is certainly one of the cannabis companies to watch. Halo is well funded to fuel its ambitious growth plans; moreover, halo has already proven that it’s as bold as it is ambitious. Halo has established an important footing in key U.S. markets California and Oregon with a base in the famous ‘Emerald Triangle’, one of the most prolific cannabis producing areas in the world. While Halo has become associated with interesting derivative items such as the Shatterizer and DabTabs (Source: MidasLetter), through partnerships and other agreements, perhaps the most notewoirthy aspect from an investment perspective is the company’s focus on ‘biomass’.
Biomass is the key to Halo’s aim to offer the highest possible quality product, whether it’s recreational or medical. While customers can revel in the quality, investors can enjoy the fact that Halo maximizes its resources, extracting every possible ounce of product, controlling the entire process of production to maximize earnings potential. Using a less ‘bombastic’ term, Halo deals in that often discussed, but rarely executed, practice of efficiency. While, the company boasts a six-acre grow facility, it uses all the buds to produce – using organic methods – its cannabis biomass, projecting anywhere from 12,000 to 18,000 pounds of flower for the current season. Meanwhile, in Cathedral City (CA), Halo extracts, processes and manufactures its distillates for California. Subsequently, after Halo filters the various fats and waxes from the biomass, the residual, which can also be used to make edibles, moves to Halo’s Nevada facility to make retail products. The crown jewel of Halo’s industrial operation in in Medford, Oregon, where it makes concentrates in a 16,000 square feet facility. Not surprisingly, Halo is the biggest producer of such cannabis derivatives in Oregon by sales amount.
[stock_chart symbol=”HALO” align=”left” range=“3M”]
The entire Halo operation not only helps it establish a leading market position (vying for pole position in view of greater de-regulation), it helps it build brand recognition, which offers an undisputable marketing advantage, matched only by the company’s ability to diversify its range. Finally, Halo is establishing a wide distribution network, having entered into the final stages of acquiring the five hectare (with a government approved potential for expansion to 200 hectares) Bophelo Bioscience & Wellness (Pty) Ltd. In Lesotho – one of the countries with the deepest cannabis cultures worldwide (Source: MidasLetter). The cannabis market in Africa, may not be the first that investors think about, but it may well become one of the most significant in the near future.
Admittedly, while trading volume has increased considerably, most cannabis stocks – Halo included – have suffered lately. One of the major catalysts for the profits – and therefore the stock price performance – of the emerging cannabis companies will be the legalization of the ‘derivatives’ market – such as cannabis infused edibles, beverages, as well as vaping and such related products as shatter. That, in conjunction with the opening of the first official cannabis retail stores in Canada (Ontario, the most populous Province, in particular) and access to other markets should help the sector fulfill a great deal, if not in whole, of the considerable hopes and expectations that many investors have placed in the cannabis sector. The sector, in many ways, has fallen victim to its own success and its own huge potential. But, investors have become more impatient than ever and their expectations, to be fair, unrealistic. The legalization of cannabis has, doubtless, opened many possibilities for successful entrepreneurship. But, that same legalization process has been patchy. The Canadian government, the second in the world to legalize recreational cannabis use, has exploited the political benefits of its move, but has yet to deliver it. Many players, meanwhile, have acted much faster than the regulation in response to the market. If revenues have disappointed investors so far, it’s not because of poor products, poor companies or insufficient supply. It’s because the regulatory framework is still wrought with obstacles. Indeed, there is good news, based on the performance of some of the biggest new players. Revenues and demand are rising. Many cannabis companies have reported their best quarters – by revenue – to date. The results prove that the cannabis market exists and it’s effervescent. And the companies that will succeed when the regulatory environment normalizes, taking full advantage of it, need to have command of the product from the raw material to the various derivatives and distribution networks established.
**IMPORTANT! BY READING OUR CONTENT YOU EXPLICITLY AGREE TO THE FOLLOWING. PLEASE READ CAREFULLY**
Notice for Forward-Looking Information Certain statements in this press release are forward-looking statements and are prospective in nature. Forward-looking statements are not based on historical facts, but rather on current expectations and projections about future events, and are therefore subject to risks and uncertainties which could cause actual results to differ materially from the future results expressed or implied by the forward-looking statements. Such forward-looking information includes that HALO Labs Inc will be a big, successful company in the cannabis sector; that cannabis use and sales will grow and HALO’s sales along with it; HALO’s intended acquisition of various foreign companies and expansion into the US market; that extraction is and will continue to be a fast growing and profitable sector of the cannabis industry; that HALO will reach $48M in revenues in 2019; HALO’s plans to produce concentrates and sell them in various locations throughout the world; that HALO could be granted licenses to expand; and that it will be able to carry out its business plans.
Readers are cautioned to not place undue reliance on forward-looking information. Forward looking information is subject to a number of risks and uncertainties that may cause actual results or events to differ materially from those contemplated in the forward-looking information, and even if such actual results or events are realized or substantially realized, there can be no assurance that they will have the expected consequences to, or effects on HALO. Such risks and uncertainties include, among other things: that a regulatory approval that may be required for the intended acquisitions and subsequent sales are not obtained or are obtained subject to conditions that are not anticipated; growing competition for intended acquisitions in the cannabis industry; potential future competition in the markets HALO operates for sales; competitors may quickly enter the industry; general economic conditions in the US, Canada and globally; the inability to secure financing necessary to carry out its business plans; competition for, among other things, capital and skilled personnel; the possibility that government policies or laws may not permit legal cannabis sales or growth or that favorable laws in place may change; HALO not adequately protecting its intellectual property; interruption or failure of information technology systems; the cannabis market may not grow as expected; HALO’s technology may not achieve the expected results and its accomplishments may be limited; even if it is granted patents, it may not have success at licensing its technologies or sell its products at the rate expected; planned acquisitions and partnerships may not materialize because of inability to agree on terms with prospective partners or targets; HALO’s business plan also carries risk, including its ability to comply with all applicable governmental regulations in a highly regulated business; incubator risk investing in target companies or projects which have limited or no operating history and are engaged in activities currently considered illegal under US federal and foreign laws; and other regulatory risks relating to HALO’s business, financings and strategic acquisitions, including securities laws, trade rules, and foreign country regulation that is not the same as Canadian or US regulations.
PAID ADVERTISEMENT. This communication is a paid advertisement and is not a recommendation to buy or sell securities. James West, Global Financial Network Ltd. and Midas Letter Media Corp. and their owners, managers, employees, and assigns (collectively “the Company”) has been paid by the profiled company or a third party to disseminate this communication. In this case the Company has been paid by HALO $300,000 US dollars for a newsletter campaign and certain banner ads, and a budget of $450,000 is in place to place newsletters in social and other media. This compensation is a major conflict with our ability to be unbiased, more specifically:
This communication is for entertainment purposes only. Never invest purely based on our communication. Gains mentioned in our newsletter and on our website may be based on end-of- day or intraday data. We have been compensated by HALO to conduct investor awareness advertising and marketing for HALO. Therefore, this communication should be viewed as a commercial advertisement only. We have not investigated the background of the profiled company. The profiled company or its affiliates may liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Frequently companies profiled in our newsletters experience a large increase in volume and share price during the course of investor awareness marketing, which often end as soon as the investor awareness marketing ceases. The investor awareness marketing may be as brief as one day, after which a large decrease in volume and share price is likely to occur.
We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our communications and on our website is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public and non-public sources but is not researched or verified in any way whatsoever to ensure the information is correct.
SHARE OWNERSHIP. The Company, which includes the owner and publisher of the Midas Letter owns shares and/or stock options of this featured company and therefore has an additional incentive to see the featured company’s stock perform well. The Company will not notify the market when it decides to buy or sell shares of this profiled company in the market. The Company may be buying and selling additional shares of the featured company for its own profit. This is why we stress that you conduct extensive due diligence as well as seek the advice of your financial advisor or a registered broker-dealer before investing in any securities.
NOT AN INVESTMENT ADVISOR. The Company and its affiliates are not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. ALWAYS DO YOUR OWN RESEARCH and consult with a licensed investment professional before making an investment. This communication should not be used as a basis for making any investment.
INDEMNIFICATION/RELEASE OF LIABILITY. By reading this communication, you agree to the terms of this disclaimer, including, but not limited to: releasing the Company, its affiliates, assigns and successors from any and all liability, damages, and injury from the information contained in this communication. You further warrant that you are solely responsible for any financial outcome that may come from your investment decisions.
RISK OF INVESTING. Investing is inherently risky. While a potential for rewards exists, by investing, you are putting yourself at risk. You must be aware of the risks and be willing to accept them in order to invest in any type of security. Don’t trade with money you can’t afford to lose. This is neither a solicitation nor an offer to Buy/Sell securities.
Midas Letter is provided as a source of information only, and is in no way to be construed as investment advice. James West, the author and publisher of the Midas Letter, is not authorized to provide investor advice, and provides this information only to readers who are interested in knowing what he is investing in and how he reaches such decisions.
Investing in emerging public companies involves a high degree of risk and investors in such companies could lose all their money. Always consult a duly accredited investment professional in your jurisdiction prior to making any investment decision.
Midas Letter occasionally accepts fees for advertising and sponsorship from public companies featured on this site. James West and/or Midas Letter may also receive compensation from companies affiliated with companies featured on this site. James West and/or Midas Letter also invests in companies on this site and so readers should view all information on this site as biased.